The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies. (Record no. 27751273)

MARC details
000 -LEADER
fixed length control field 01482 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517183345.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201711s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1532-1967
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ctrv.2017.09.011
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cortés, Javier
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20171120
245 00 - TITLE STATEMENT
Title The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer treatment reviews
Date of publication, distribution, etc. Dec 2017
300 ## - PHYSICAL DESCRIPTION
Extent 53-60 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclin-Dependent Kinase 4
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclin-Dependent Kinase 6
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phosphoinositide-3 Kinase Inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, ErbB-2
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Estrogen
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element TOR Serine-Threonine Kinases
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Im, Seock-Ah
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Holgado, Esther
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Perez-Garcia, Jose M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schmid, Peter
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chavez-MacGregor, Mariana
773 0# - HOST ITEM ENTRY
Title Cancer treatment reviews
Related parts vol. 61
-- p. 53-60
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ctrv.2017.09.011">https://doi.org/10.1016/j.ctrv.2017.09.011</a>
Public note Available from publisher's website

No items available.